This article highlights a personal account illustrating medicine's failure to treat seriously a heart condition experienced by 20% of women. Describes Mitral Valve Prolapse; association between MVP and endocarditis.
Lettre de plainte à Santé-Canada: publicité « étiquette d'orteil » de Pfizer, 2004.
Owning Org:
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type:
Online
Author:
Anne Rochon Ford
This letter to Health Canada argues that the pharmaceutical manufacturer, Pfizer, has been running television ads with misleading information on cardiovascular risks and using Canadian's fear of death from heart disease in order to promote sales of its product. It urges Health Canada to take regulatory action on this campaign.
This article describes the POWER (Project for an Ontario Women's Health Evidence-Based Report) Study who are producing a women's health equity report that measures the health of Ontarians, the performance of the health care system , gender differences in access to, quality and outcomes of care for the leading causes of morbidity and mortality. A full copy of the POWER study report is available online at http://www.powerstudy.ca/the-power-report/the-power-report-volume-1/cardiovascular-disease.
Report illuminates the gender gap when it comes to heart disease and stroke. Demonstrates that Canadian women's progress has not kept pace with men's by comparing the number of deaths from heart disease and stroke experienced by women versus men.
Explains in what ways heart disease affects women differently than men. Lists the symptoms of angina and heart attack, risk factors, challenges women face in managing heart disease, and lifestyle changes that will help.
Presents a ten-part television series designed to help Black women learn practiical strategies to improve their heart health. Covers topics such as diabetes, blood pressure, stroke, cholesterol, healthy weights, stress, smoking, and advocacy.